sumatriptan succinate and naproxen sodium
Generic: sumatriptan succinate and naproxen sodium
Labeler: currax pharmaceuticals llc dba cypress, hawthorn, macovenDrug Facts
Product Profile
Brand Name
sumatriptan succinate and naproxen sodium
Generic Name
sumatriptan succinate and naproxen sodium
Labeler
currax pharmaceuticals llc dba cypress, hawthorn, macoven
Dosage Form
TABLET
Routes
Active Ingredients
naproxen sodium 500 mg/1, sumatriptan succinate 85 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
44183-850
Product ID
44183-850_e0a82608-7b67-4d15-a04a-16e6c341c621
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA021926
Listing Expiration
2026-12-31
Marketing Start
2015-05-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
44183850
Hyphenated Format
44183-850
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sumatriptan succinate and naproxen sodium (source: ndc)
Generic Name
sumatriptan succinate and naproxen sodium (source: ndc)
Application Number
NDA021926 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
- 85 mg/1
Packaging
- 9 TABLET in 1 BOTTLE (44183-850-09)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e0a82608-7b67-4d15-a04a-16e6c341c621", "openfda": {"upc": ["0344183850091"], "unii": ["9TN87S3A3C", "J8BDZ68989"], "rxcui": ["849450"], "spl_set_id": ["5762bbe6-bddf-495c-adf8-9096f98a3a9c"], "manufacturer_name": ["Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "9 TABLET in 1 BOTTLE (44183-850-09)", "package_ndc": "44183-850-09", "marketing_start_date": "20180215"}], "brand_name": "Sumatriptan Succinate and Naproxen Sodium", "product_id": "44183-850_e0a82608-7b67-4d15-a04a-16e6c341c621", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Serotonin 1b Receptor Agonists [MoA]", "Serotonin 1d Receptor Agonists [MoA]", "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"], "product_ndc": "44183-850", "generic_name": "sumatriptan succinate and naproxen sodium", "labeler_name": "Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sumatriptan Succinate and Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "500 mg/1"}, {"name": "SUMATRIPTAN SUCCINATE", "strength": "85 mg/1"}], "application_number": "NDA021926", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20150514", "listing_expiration_date": "20261231"}